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a  b  s  t  r  a  c  t
This publication  presents  the  assessment  of the impact  of  genetically  modiﬁed  (GM)
LibertyLink® maize  on reproductive  function,  prenatal  and postnatal  progeny  development
of  Wistar  rats  over  three  generations.  The animals  were  divided  into  two  groups,  which
were  fed  with  rodent  diet  with  inclusion  of  GM  LibertyLink® (‘test’  group)  and  non-GM
near-isogenic  counterpart  (‘control’  group)  maize  varieties.  The  maize  was  included  into
the diet  at  maximum  possible  level  (between  32  and  33%)  not  causing  nutritional  imbalance
or  metabolic  disturbance  for the  experimental  animals.
Data analysis  showed  no  impact  of  LibertyLink® maize  on the animals’  fertility:  the
observed  mating  efﬁciency  in both  groups  was within  the normal  expected  range  values
under the  given  experiment  conditions.  The  comparison  of progeny  prenatal  development
in  the  generations  F0–F2  has not  shown  any  differences  between  the groups.  Analysis  of
the  physical  development  of  the F0–F2  progeny  or pups  body  weight  and  length  progress
did  not  show  any  abnormalities.  The  average  number  of  pups  per  litter  in  the  control  and
test groups  was  within  the  expected  range  of  variations.  Therefore,  the  results  should  be
considered  as direct  evidence  of  the  lack  of  any  reproductive  toxicity  of LibertyLink® maize
(a.k.a.  T25 maize).
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  B
1. Introduction
During the past 17 years, GM crops have been broadly
adopted. For the period from 1996 to 2013 the global
acreage of GM crops increased more than 100-fold, hav-
ing  reached 175.2 million hectares. According to leading
experts, the 50% of World agricultural production will have
been  reached with the excessive use of biotechnology by
2030  [1].
∗ Corresponding author. Tel.: +7 495 6985364.
E-mail address: tnv@ion.ru (N.V. Tyshko).
http://dx.doi.org/10.1016/j.toxrep.2014.05.013
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
(http://creativecommons.org/licenses/by-nc-nd/3.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Analysis of publications on GMO  safety research var-
ied  by design, duration of study, and parameters set leads
us  to the conclusion that the studies carried out under
the  standard requirements in terms of the selection of
appropriate samples, selection of animals, diet, living con-
ditions,  etc., has shown no negative impact of GMOs on
the  studied parameters [2–10]. In this case the ‘standard
requirements’ mean that the experimental design meets
the  FAO/WHO/OECD recommendations [11–13] on the
safety  assessment of GMO.On  the contrary, the majority of experiments con-
ducted with deviations from the standard requirements
on the safety assessment of GMO  [11–13], has shown
exactly the opposite results. Well-known examples of such
is is an open access article under the CC BY-NC-ND license
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ublications are articles of [14–20] and so on. Neverthe-
ess, the debate of this issue is still on, so the completion
f science-based evidence of GMO  safety has not lost its
elevance, particularly, in the ﬁeld of the next generations’
ealth.
The system of state registration of genetically modi-
ed (GM) plants in the Russian Federation includes several
oxicological studies, which can be completed by genotox-
cological, allergenicity and/or reprotoxicity testing on ad
oc  basis. According to established researcher practice, the
MO  reprotoxicity study was optional [21,22], but since
011  the safety assessment of new GM events within their
tate  registration procedure in Russia has also involved the
eproductive toxicity studies in experimental animals gen-
rations.
The  laborious and time-consuming reproductive toxic-
ty  methods are a serious restriction of their application.
owever, their high sensitivity and predictability, focus-
ng  on detailed assessment of the health status of the next
enerations, can be an important argument in favor of con-
ucting  investigations of this kind [23–25].
The purpose of the current work was to study the
mpact of GM LibertyLink® maize on reproductive func-
ion  and progeny development of Wistar rats over three
enerations. The animals have been fed with rodent diet
ontaining GM LibertyLink® maize.
GM LibertyLink® maize by Bayer CropScience company
ame out on the market in the year 1995. This line was
eveloped through chemically mediated transformation
f cultured protoplasts obtained from a yellow dent corn
Zea  mays ssp. Linnaeus) with puriﬁed DNA containing
he pat gene isolated from S. viridochromogenes utilizing
UC/Ac vector. Vector pUC/Ac contains a pat gene expres-
ion  cassette that encodes synthesis of Phosphinotricin
-acetyltransferase enzyme and a bla gene expression cas-
ette  included as a selectable marker. The presence of pat
ene  determines this maize line’s resistance to glufosi-
ate ammonium (the active ingredient in phosphinothricin
erbicides — Basta, Rely, Finale, and Liberty), the bla gene
s  not functional in the modiﬁed maize line, as its pro-
oter is only active in bacteria. Protein Pat content in GM
ibertyLink® maize tissues is ∼0.003% of the total protein
26].
Genetic and phenotypic stabilities of the trait were
ustained in several-generations studies of LibertyLink®
aize. The maize progeny resistance to glufosinate ammo-
ium  is inherited as a dominant trait according to
endelian principles [26].
GM LibertyLink® maize risk assessment was carried out
n  accordance with the recommendations of the WHO,
he  Commission “Codex Alimentarius”, and the Ofﬁce of
he  Food and Drug Administration, U.S. Government (Food
nd  Drug Administration) and others [11,12,27–29]. The
ssessment included the GM maize substantial equivalence
valuation compared to its conventional counterpart [30];
he  toxic and allergenic properties estimation of the protein
esponsible for the resistance to glufosinate ammonium
anifestation; the toxic and allergenic properties estima-
ion  of LibertyLink® maize grain.
The received data indicate compositional equivalence of
M  maize compared to its traditional counterpart (basedports 1 (2014) 330–340 331
on  analysis of more than 30 indicators), the absence of toxic
and  allergenic properties of the protein Pat (based on the
number of tests, which included the in vivo study of acute
toxicity by oral administration, the in vitro determination
of resistance to proteolytic degradation in simulated mam-
malian  gastrointestinal ﬂuids, etc.) and the absence of toxic
and  allergenic properties of the GM LibertyLink® maize
(based on both in vitro and in vivo experiments) [22,26].
The  results of these studies have led to entering the food
market in the Argentina, Australia, Brazil, Canada, China,
Colombia, the European Union, Japan, Malaysia, Mexico,
New  Zealand, the Philippines, Russian Federation, South
Africa,  South Korea, Taiwan, USA, with GM LibertyLink®
maize [26].
The  decision to conduct the reproductive toxicity study
was  to broaden the knowledge base and to conﬁrm that
studies, required by the Russian regulations are sufﬁcient
to  address the safety of GM plants.
In this very feature the research results of rat’s
reproductive function, prenatal and postnatal progeny
development are presented.
2.  Materials and methods
2.1.  Experimental design and treatment
The experiment was performed on two  animal groups
from September 2007 to October 2008. The animals in
the  ‘test’ group were exposed to diet containing the
LibertyLink® maize, the animals in the ‘control’ group were
exposed to the non-GM near-isogenic counterpart. The ani-
mals  had been fed with the experimental diets during the
entire  period of the study.
The  experiment was conducted in two  stages: the 1st
stage  was  preparatory for generation F0 rats breeding. Gen-
eration  F0 rats had been receiving the experimental diets
during the whole ontogenetic development time and were
optimally  standardized for the purpose of this research. In
this  case, the animals standardization consisted of females
and  males selection from litters similar in number of pups
and  progeny survival skills. The 2nd stage was  the direct
reproductive function study of generations F0 and F1 rats,
and  progeny F2 development. A total of 380 adult ani-
mals and 1540 of pups were included in the experiment
(Table 1).
The  basic colony rats (Fb, males and females age ∼30–35
days) fed on conventional rodent diet [31] were randomly
divided into two  groups and were switched to the above
mentioned customized corn diets.
In order to impregnate females, they were housed
together with males in 2:1 ratio for the equivalent of one
estral  cycle (5 days). During the mating period, the rats’
age  was 100–120 days. Pups were set apart from parental
animals on the 26th day of life. The progeny was randomly
selected from different females in order to minimize the
chance  of incest breeding during the course of the experi-
ment.
The  study design was adapted from Medico-biologic
safety assessment of genetically engineered and modiﬁed
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Table  1
Composition of the experimental groups and number of animals.
Group Fb F0 F1 Total
Control
group
Adults  35♀ + 20♂ 50♀ + 25♂ 40♀ + 20♂ 190
Progeny  236 300 242 778
iment oTest
group
Adults  35♀ + 20♂ 
Progeny  162 
A total of 380 adult animals and 1540 of pups were included in the exper
organisms of plant origin: Methodological instructive reg-
ulations  MU 2.3.2.2306-07 [31].
2.2. Ethics
The experimental protocol was conducted in accor-
dance with the regulations of ‘On approval of the Good
Laboratory Practice rules’ authorized by the Ministry of
Healthcare of the Russian Federation (Order No 267 dated
July  19, 2003). Federal State Budgetary Institution “Insti-
tute  of Nutrition” under the Russian Academy of Medical
Sciences (FSBI “Institute of Nutrition” RAMS) strictly fol-
lows  standard procedures of the humane use of laboratory
animals as well as in requirements regarding the keeping
and  breeding of laboratory animals in nurseries and vivar-
iums  and their use in scientiﬁc, educational and industrial
purposes. The research materials were reviewed by the
Ethics  Committee of the Institute of Nutrition (protocol No.
6  dated December 20, 2010).
2.3. Animals
The basic colony rats (Fb, males and females age ∼30–35
days) were received from the animal nursery ‘Stolbovaya’
of the Russian Academy of Medical Sciences.
Rats had been kept in plastic cages with wood shav-
ings, in heated (T ∼20 to 23 ◦C) and ventilated room with
natural light. They had free (ad libitum) access to conven-
tional rodent diet [31] and water. The number of rats in
one  cage was 3 (2♀:1♂) during mating period, one female
with her pups during birthing and lactation periods. During
intermediate periods there were 3–5 rats of the same sex
in  one cage. Animals continued on experimental diets for
all  period of experiment (from September 2007 to October
2008).
All  animals were observed once daily for mortality,
moribundity and for overt signs of toxicity. Individual body
weights  were obtained once weekly for 30–100 days of age.
Pups’  body weight and length were measured on post-natal
days  2, 5, 10, 15, 20 and 25th. Individual food consumption
was considered on 30, 45 and 90 days of life.
2.4. Maize samples
The  samples of LibertyLink® maize and the non-GM
near-isogenic counterpart were used. The samples had
been  grown under identical conditions (i.e. same plant-
ing  locations in the USA and processing). The material was
provided  by Bayer CropScience.
All maize grain samples were assessed to conﬁrm
that they met  the sanitary requirements of the Russian50♀ + 25♂ 40♀ + 20♂ 190
354 246 762
ver three generations.
Federation (Sanitary and Epidemiological rules and reg-
ulations,  SanPiN 2.3.2.1078-01) [31,32]. The hygenic
investigation included the detection of heavy metals,
pesticides, mycotoxins and benz(a)pyren content (Table 2).
The  fumonisins content showed slight variations between
the  different maize samples. The fumonisin’s daily intake
was  estimated for each experimental group: in the ‘test’
group’s diet the fumonisin contents was  <0.0128 mg/kg
(0.00085–0.00128 mg/kg of body weight), in the ‘con-
trol’ group’s diet the fumonisin content was  0.0173 mg/kg
(0.00115–0.00173 mg/kg of body weight) respectively. As
described  in available sources, kidneys are the most sensi-
tive  target organ for fumonisins as far as rats are concerned,
with a NOAEL equal to 15 mg/kg of feed (corresponding
to 0.25 mg/kg of body weight) [33–35]. In conclusion, the
fumonisin levels were shown to be signiﬁcantly lower than
the  NOAEL. So the observed fumonisin level variations
between the different maize samples would have a minor
biological incidence and the safety impact should be neg-
ligible.
2.5.  Animal diet preparation
The  maize grain processing included a gradual whole
grain reduction by grinding with micro-mill equipment
until the condition of ﬂour substance consisting of
400–500 m particles. The milled grain was  included into
the  diet to achieve an exposure of 8–10 g/rat/day. Diet
ingredient formula was  adjusted in order to produce nutri-
tionally  balanced diets, in accordance with the principle of
isocaloricity and equivalence of chemical composition of
diets  [31]. The diet compositions are presented in Table 3.
2.6.  Reproduction and developmental assessment
The assessment of the reproductive function was
focused on the fertility of parent animals’ as well as on pre-
natal  and postnatal development characteristics of the F0,
F1 and F2 progenies. In the context of this study, the mat-
ing  efﬁciency (fertility) was  deﬁned as the ability of males
to  impregnate females, or as the proportion of females to
be  impregnated. The fertility index was taken as a ratio
of  fertilizing ability of males over the total number of co-
housed  males, or as a ratio of pregnant females over the
total  number of co-housed females. Since the females were
put  together with males in 2:1 ratio, pregnancy of both, or
either  female(s) conﬁrmed male’s fertilizing ability. In case
neither  of the females has become pregnant, the male was
not  considered to be fertile and the females were consid-
ered  potentially fertile.
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Table 2
Sanitary evaluation and chemical composition of maize samples.
Studied indicator Near-isogenic control GM maize Sanitary norms [32]
Toxic elements (mg/kg)
Lead  n/d n/d 0.5
Arsenicum n/d n/d 0.2
Cadmium n/d n/d 0.1
Mercury n/d n/d 0.03
Pesticides (mg/kg)
Hexachlorcyclohexane n/d n/d 0.5
DDT and its metabolites n/d n/d 0.02
Aldrine n/d n/d –
Hexachloran n/d n/d –
Heptachlor n/d n/d –
Kelthane n/d n/d –
Organic-mercury pesticides n/d n/d Not admitted
2,4-D  acid, its salts and ethers n/d n/d Not admitted
Benz(a)pyren n/d n/d 0.001
Mycotoxins (mg/kg)
Aﬂatoxin  B1 n/d n/d 0.005
Desoxynivalenol n/d n/d –
T-2 toxin 0.015 ± 0.005 0.011 ± 0.006 0.1
Zearalenon n/d n/d 1.0
Fumonisin B1 0.054 ± 0.038 n/d –
Fumoinisin B2 n/d n/d –
Chemical composition
Protein  (%) 8.54 ± 0.09 9.32 ± 0.06 –
Fat (%) 4.14 ± 0.27 4.45 ± 0.32 –
Carbohydrates (%) 61.40 ± 0.62 60.86 ± 0.32 –
Sum of alimentary ﬁbers (%) 15.64 ± 0.54 15.12 ± 0.32 –
Ash (%) 1.12 ± 0.11 1.05 ± 0.09 –
Moisture (%) 9.07 ± 0.47 9.23 ± 0.48 –
Calories (kCal) 311.8–322.3 316.4–325.2 –
n/d = non deﬁned.
N = 12.
The samples of LibertyLink® maize and the non-GM near-isogenic counterpart had been grown under identical conditions (i.e. same planting locations in
the  USA and processing). The material was provided by Bayer CropScience.
Table 3
Composition of the experimental diets with inclusion of maize.
Diet ingredients Weight (g) Protein (g) Fat (g) Carbohydrates (g)
Test group (GM maize)
Casein  19.7 16.7 0.3 0.0
Maize starch 34.6 0.3 0.0 30.0
Sunﬂower oil 3.7 0.0 3.7 0.0
Lard 5.0 0.0 5.0 0.0
Salt mixturea 4.0 0.0 0.0 0.0
Mixture of w/s  vitaminsa 1.0 0.0 0.0 1.0
Mixture of o/s vitaminsa 0.1 0.0 0.1 0.0
Maize meal 32.0 2.7 1.3 19.6
Total g  100.1 19.7 10.4 50.6
kCal  374.8 78.8 93.6 202.4
Control group (near-isogenic maize)
Casein 19.3 16.3 0.3 0.0
Maize starch 34.0 0.3 0.0 29.4
Sunﬂower oil 3.5 0.0 3.5 0.0
Lard 5.0 0.0 5.0 0.0
Salt mixturea 4.0 0.0 0.0 0.0
Mixture of w/s  vitaminsa 1.0 0.0 0.0 1.0
Mixture of o/s vitaminsa 0.1 0.0 0.1 0.0
Maize meal 33.1 3.1 1.5 20.1
Total g  100.0 19.8 10.4 50.5
kCal  374.8 79.2 93.6 202.0
a Diet ingredient formula was adjusted in order to produce nutritionally balanced diets, in accordance with the principle of isocaloricity and equivalence
of  chemical composition of diets [31].
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For prenatal development assessment of 9–11 females
from Fb, F0 and F1 of each group were euthanized on the
20th  day of pregnancy (one day prior to the expected
day of delivery). The uteruses were removed by cesarean
section and the uteruses and the fetuses were examined.
The females were examined macroscopically for any struc-
tural  abnormalities or pathological changes.
The number of ovarian corpora lutea, resorptions,
implantation sites, the number of alive and dead fetuses,
the  pre-implantation loss (i.e. difference between the num-
ber  of ovarian corpora lutea in ovaries and the number
of  implantation sites in uterus) as well as the post-
implantation loss (i.e. difference between the number
of  implantation sites in uterus and the number of alive
fetuses) were determined.
Postnatal  F0, F1 and F2 progeny development was being
assessed during the ﬁrst month of life by counting the
number of alive and dead pups, dynamic of body weight
and  length, physical developmental landmarks (i.e. ear
unfolding, ﬁrst coat, incisor eruption, eye opening, testicle
lowering, vagina opening). Pups’ body weight and length
were  measured on post-natal days 2, 5, 10, 15, 20 and 25th.
The  average litter size, the male-to-female ratio and the
postnatal survival index were calculated from 1st to the
5th  day of life (i.e. the ratio between the number of pups
being  alive on the 5th day to the total number of pups born
alive)  and from the 6th to the 25th day of life (i.e. ratio
between the number of pups being alive on the 25th day to
the  total number of pups being alive on the 5th day). This
assessment was performed in accordance with the Russian
Guidelines [21,31] and was also considering the US FDA and
OECD  methodical guidelines [13,36].
2.7. Statistical analysisAccording  to the experiment structure the comparison
between control and GM-fed groups has been performed.
Data were presented as M ± SE and min–max, where M was
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the  mean, SE was  the standard error, and min–max were
the  minimal and maximal values, as well as percentage or
absolute  ﬁgures.
Statistical analysis was  executed with the use of
SPSS 17.0 software package (IBM, USA). The homogene-
ity of variance and normal distribution between groups
was  determined by chi-square test, while the variance
equality was  measured by Levene’s test. Reliability assess-
ment  of the mean ﬁgures differences of data normally
distributed was analyzed by one-way ANOVA. For com-
parison of quantitative parameters not being normally
distributed, non-parametric test was  applied (U-criterion
of  Mann–Whitney). Statistical signiﬁcance was  assigned at
the  p < 0.05 level [37,38].
3. Results and discussion
3.1.  Clinical signs and mortality
Throughout  the study, no adverse effects on Fb–F2 ani-
mals’ behavior were observed. The animals were examined
once  daily for well-being. The food and water consump-
tion, appearance and growth of test group rats illustrate
normal and similar health condition patterns within and
between the two groups. No mortality was  recorded during
the  experiment period.
3.2.  Body weight progress and food consumption
Weekly body weight progress in all groups of rats at
the  age of 30–93 days followed the Wistar rats’ normal
body weight progress (Figs. 1–3) that corresponds with
data  of reliable sources [39–42] as well as the results of
the  similar experiment with conventional maize varieties
conducted by FSBI “Institute of Nutrition” RAMS. Food con-
sumption  was  generally similar between test and control
groups, and fell within 13.3–29.4 g/rat/day for males and
12.4–25.7 g/rat/day for females in the Fb–F1 generations.
Test group
Female
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Weekly body weight progress of pregnant females was
n  whole comparable for both groups. There were no
tatistically signiﬁcant differences observed between the
est  and control groups.
.3.  Reproductive function
Key  indicator of reproductive function is the mating
fﬁciency, proving experimental animals’ fertility. As pre-
ented  in Table 4, the females’ mating efﬁciency was
1–92%, 79–80% and 77–87% in the Fb, F0 and F1 gener-
tions. The males’ mating efﬁciency was 100%, 89–95% and
00%  accordingly. The maximum ﬂuctuations range of this
arameter, for both females and males, was revealed in the
asic  colony of rats just received from the external animal
ursery. The minimum ﬂuctuations range was revealed inht progress.
the  F1 generation, grown under the standardized vivarium
conditions.
The  observed mating efﬁciency in both groups was in
the  normal expected range values under the given exper-
iment  conditions [21,43], that matches with the results of
the  comparable experiment with conventional maize vari-
eties.
The  duration of co-housing period (5 days) was  equal
to  the mean rat’s estral cycle duration [21]; however, in
accordance with Mandl [43], 11–28% of rats may  have a
longer  estral cycle duration (5.5–10 days). Therefore, it is
very  likely that some of co-housed females never reached
estrus phase during the given time period for this particular
reason. The number of males considered non-fertile, fell in
the  range of physiological variations [44] and varied within
0–13%.  Several ﬂuctuations of mating efﬁciency in control
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Table  4
Mating efﬁciency.
Generation Group Gender Number of co-housed rats Number of impregnate♀/number of fertile ♂ Mating efﬁciency
a, %
Fb
Control group
♀ 24 22 92♂ 12 12 100
Test  group
♀ 24 17 71♂ 12 12 100
F0
Control group
♀ 38 26 79♂ 19 17 89
Test  group
♀ 40 30 80♂ 20 19 95
F1
Control group
♀ 30 26 87♂ 15 15 100
Test  group
♀ 30 23 77♂ 15 15 100
a The fertility index was  taken as a ratio of fertilizing ability of males over the total number of co-housed males, or as a ratio of pregnant females over the
total  number of co-housed females. Since the females were put together with males in 2:1 ratio, pregnancy of both, or either female(s) conﬁrmed male’s
ale wafertilizing  ability. In case neither of the females has become pregnant, the m
fertile.
and test groups had no deﬁnite tendency and were thus
considered as incidental and not connected with external
factors.
3.4.  Prenatal development
The  comparison of progeny prenatal development in
the  test and the control groups of generations F0–F2
(Table 5) has not shown any signiﬁcant differences
between the groups. The number of ovarian corpora-
lutea, resorption and implantation sites, the number of
alive  and dead fetuses, the pre-implantation loss fell
within the typical range for Wistar rats physiological vari-
ations  (Table 6). Spontaneous post-implantation loss in
the  F0–F2 control and test groups embryos was slightly
lower than the normal range of 3.6–9.2% (Table 5). In the
generation F0 post-implantation loss was 0%, in genera-
tion F1 it was 0% in the control group and 0.9 ± 0.9% in the
Table 5
Prenatal development of progeny F0, F1 and F2.
Recorded indicators Generation F0
Control group Test group 
Number of pregnant females 10 10 
Number  of ovarian
corpora-lutea
Total 117 104 
M ± SE 11.70 ± 0.72 10.40 ± 0.58 
Min–max 9–15 8–14 
Number  of
implantation sites
Total 109 94 
M ± SE 10.90 ± 0.67 9.40 ± 0.70 
Min–max 7–14 6–13 
Number  of alive
fetuses
Total 109 94 
M ± SE 10.90 ± 0.67 9.40 ± 0.70 
Min–max 7–14 6–13 
Number  of dead fetuses 0 0 
Number  of
resorptions
Total 0 0 
M ± SE – – 
Min–max – – 
Pre-implantation loss (%) 6.7 ± 2.5 10.0 ± 3.6 
Post-implantation loss (%) 0 0 
a Out of uterus pregnancy.s not considered to be fertile and the females were considered potentially
test  group, in generation F2 it was 0.8 ± 0.8% and 3.7 ± 3.0%
in  the control and test groups accordingly (Table 5).
We  should point out that similar-in-design studies have
shown  very close values of post-implantation loss over
three  generations of Wistar rats (1.2–9.9%), which conﬁrms
the  absence of treatment-related ﬁnding and illustrates a
rather  wide variation range of this parameter.
3.5. Postnatal development
Postnatal  progeny development in the test and control
groups, during ﬁrst stage of the experiment, is character-
ized by a transient decrease of F0 progeny survival rate
compared to generations F1 and F2 (Table 7). From 1st to the
5th  days of life the F0 control group’s progeny survival rate
was  96%, during the period from the 6th to the 25th days it
was  81%. In the test group of generation F0 these indicators
were 94% and 90% accordingly. The analysis of the causes
Generation F1 Generation F2
Control group Test group Control group Test group
10 9 11 11
127 117 124 142
12.70 ± 0.54 13.00 ± 0.53 11.18 ± 0.55 12.91 ± 0.55
10–15 11–15 8–14 10–16
120 107 114 132
12.00 ± 0.54 11.89 ± 0.77 10.27 ± 0.81 12.00 ± 1.04
9–14 8–14 5–14 3–16
120 106 113 131
12.00 ± 0.54 11.78 ± 0.76 10.27 ± 0.81 11.91 ± 1.12
9–14 8–14 5–14 2–16
0 1 0 0
0 0 1a 1
– – 0.09 ± 0.09 0.09 ± 0.09
– – 0–1 0–1
5.5 ± 1.3 9.1 ± 3.4 8.7 ± 4.7 8.0 ± 6.5
0 0.9 ± 0.9 0.8 ± 0.8 3.7 ± 3.0
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Table 6
Prenatal development of progeny: literature data.
Recorded indicators Literature references
[52] [45] [53] [46] [50] [48]
Number of pregnant females 26 150 15 11 47 10
Number  of ovarian corpora-lutea 12.3 ± 0.2 – 14.0 ± 0.4 14.5 ± 0.3 13.5 ± 0.2 15.8 ± 1.3
Number  of implantation sites 11.2 ± 0.4 – 13.2 ± 0.3 13.5 ± 0.39 12.6 ± 0.2 15.4 ± 1.4
Number  of alive fetuses 10.8 ± 0.4 10.6 ± 0.3 10.73 12.3 ± 0.3 11.5 ± 0.3 14.6 ± 1.9
Number  of resorptions 0.42 ± 0.2 7.2 ± 1.2 – 0 – 0
Pre-implantation  loss (%) 8.5 ± 3.0 14.1 ± 1.5 5.14 6.2 7.1 ± 1.4 –
Post-implantation  loss (%) 3.6 ± 1.4 7.4 ± 1.2 5.77 9.2 8.6 ± 1.7 4.69
Table 7
Postnatal development of progeny F0, F1 and F2.
Recorded indicators Generation F0 Generation F1 Generation F2
Control group Test group Control group Test group Control group Test group
Total number of pups 237 164 300 354 244 246
Of  those – still born 1 2 0 0 2 0
Mean  litter size (M ± SE) 10.73 ± 0.59 9.53 ± 0.59 11.54 ± 0.60 11.80 ± 0.27 9.68 ± 0.77 10.70 ± 0.50
Ratio  ♂/♀ in the litter (%) 47/53 52/48 52/48 49/51 51/49 49/51
Survival  from the 1st to the 5th day of life (%) 96 94 98 99 98 99
Number  of alive (initial)/number of died 236/10 162/10 300/7 354/4 242/4 246/1
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Number  of alive (initial)/number of died 226/44 15
f this transient higher mortality has revealed that 55% of
his  index value (24 from 44 dead pups) in control group
as  mainly due to tree litters with the total number of 32
ups  born alive. The most probable hypothesis is that the
arental  Fb females, just received from the external animal
ursery, did not have enough breast milk. This hypothesis is
upported  by the fact that the progeny death had occurred
n  the period from 6th to the 15th days of life, before the
ups  switched from breast feeding to mixed feeding, and by
he  pups’ relatively low body weight progress: on the 2nd
ay  of life the mean body weight was 6.2 ± 0.1 g (within
he normal range), on the 5th day of life it was 7.6 ± 0.2 g
∼30%  below the normal range), on the 15th day of life it
as  21.5 ± 2.7 g (∼25% below the normal range).
In the generations F1 and F2, the progeny survival rates
rom 1st to the 5th days of life were 98–99% and 95–96%
rom 6th to the 25th days of life, respectively (Table 7). Sig-
iﬁcant  differences between control and test groups have
ot  been shown.
The  observed progeny survival rates in both groups was
n  the normal expected range values that corresponds with
he  results of the similar experiment with conventional
aize varieties conducted by FSBI “Institute of Nutrition”
AMS: the progeny survival rates from 1st to the 5th day
able 8
ostnatal development of progeny: reliable sources.
Recorded indicators References
[49] [51] 
Total number of pups 215 133 
Of  those – still born 4 5 
Mean  litter size (M ± SE) 11.4 ± 0.2 11.1 ± 2.0 
Survival  from the 1st to the 5th (%) 97.0 96.0 
Survival  from the 6th to the 25th (%) 99.0 – 
Ratio  ♂/♀ 46/54 45/55 96 95 98 98
293/12 350/19 238/4 245/5
of  life were 87–99%, from 6th to the 25th day of life were
94–100%.
In  accordance with several sources [44], Wistar rats line
has  a relatively high variability of some reproductive func-
tion  indicators, including the progeny survival rate during
the  ﬁrst month of life (this index may  not exceed 68%)
(Table 8). In addition, it has been shown that standardized
living conditions help reducing the variability to a great
degree [45]. In the present study, the maximum survival
ﬂuctuations rate was observed during the ﬁrst stage of
the  experiment in progeny of Fb rats, just received from
the  external animal nursery. The minimum survival ﬂuc-
tuations rates were observed in progenies of F0 and F1
rats grown under the Institute of nutrition’s vivarium con-
ditions.  This fact speaks volumes about general keeping
conditions having key inﬂuence on the researched indica-
tors.
The  average number of pups per litter in the con-
trol and test groups were within the expected range of
variations, that agrees with the results of the own  iden-
tical  researches with conventional maize varieties (the
range  was within 9.53–11.80 pups per litter) and values
of  reliable sources (Table 8). No statistically signiﬁcant dif-
ferences  were detected between groups (Table 7). The ratio
[47] [48] [46] [44]
28 146 135 >300
1 – 1 –
9.5 ± 0.5 14.6 ± 0.6 12.3 ± 0.1 11.67 ± 0.1
99.3 – – 96.8
98.6 – – 67.9
– 48/52 47/53 47/53
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Table  9
Physical development of the pups F0, F1 and F2.
Recorded indicator Generation F0 Generation F1 Generation F2
Control group Test group Control group Test group Control group Test group
Ear unfolding, day 2.66 ± 0.08 2.71 ± 0.06 2.81 ± 0.05 2.95 ± 0.04 2.86 ± 0.08 2.89 ± 0.07
First  coat, day 5.48 ± 0.08 5.56 ± 0.13 5.31 ± 0.10 5.74 ± 0.11a 5.98 ± 0.07 5.76 ± 0.09
Incisor  eruption, day 9.07 ± 0.11 9.29 ± 0.13 9.25 ± 0.14 9.72 ± 0.12a 9.46 ± 0.04 9.59 ± 0.15
Eye  opening, day 15.05 ± 0.09 15.26 ± 0.11 15.44 ± 0.11 15.62 ± 0.14 15.18 ± 0.07 15.26 ± 0.22
Testicle  lowering, day 23.86 ± 0.11 24.00 ± 0.16 23.98 ± 0.22 23.90 ± 0.18 23.72 ± 0.22 23.97 ± 0.23
Vagina  opening, day 28.75 ± 0.09 28.97 ± 0.10 28.73 ± 0.26 28.29 ± 0.17 28.70 ± 0.12 28.83 ± 0.12
a According to the reliable sources [21,50], the normal post-natal indicators of Wistar pups physical development are as follows: ear unfolding from 2nd
day,  ﬁrst coat from 5th day, incisor eruption from 6th day, eye opening from 12th day, testicle lowering from 18th day, vagina opening from 28th day.
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Fig. 4. F0 pups body weight and length progress.
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Fig. 5. F1 pups body weight and length progress.
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[Fig. 6. F2 pups body 
etween males and females in the groups differed slightly
n  each generation. However, these variations did not have
ny  distinct trends and fell within the typical value limits
or  Wistar rats [44,46–49]. Analysis of the physical develop-
ent  of the F0–F2 progeny (ear unfolding, ﬁrst coat, incisor
ruption, eye opening and others) (Table 9) or pups body
eight  and length progress (Figs. 4–6), did not show any
bnormalities [48–51].
.  Conclusion
In  conclusion, the ﬁndings from rat fed diets containing
ibertyLink® maize were similar to those fed diets con-
aining non-GM near-isogenic counterpart. The evaluation
f  LibertyLink® maize potential reproductive toxicity over
hree  generations of Wistar rats has not revealed any neg-
tive  impacts on the reproductive function or on the pre-
nd  post-natal rat progeny development.
The obtained data corresponds with the results of the
dentical reproductive toxicity study performed with con-
entional  maize varieties, as well as a review of published
nformation and demonstrates that the reproduction and
evelopment ﬁndings observed with LibertyLink® maize
ere  within the normal range of variations for the various
tudied parameters. Therefore, the results of this investi-
ation should be considered as evidence of the lack of any
egative  impact of GM LibertyLink® maize on the repro-
uctive function and Wistar rats’ progeny development.
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